ARCHIVES

What Should NCI Do When Center Directors Leave? Kimes Asks

This article is from The Cancer Letter archive.

Vol. 18 No. 30 | July 24, 1992

Download PDF Visit The Full Archive

Related Articles

NCI Cancer Education Program To Open To Innovative Ideas

April 2, 1993

Drug Approvals: FDA Approves Vectibix in mCRC With KRAS Companion Diagnostic

May 30, 2014

Development Of New Screening System For Antimetastasis Drugs Approved

June 25, 1982

NIH Director Calls For Lifting Federal Ban on Embryonic Stem Cell Research.

March 23, 2007

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

November 6, 1998

HHS Proposes Six New DRGs for Leukemia, Lymphoma

July 4, 1986